[68Ga]Ga-GZP and [18F]FDG PET for early response prediction in locally advanced rectal cancer undergoing neoadjuvant immunochemoradiotherapy
Authors:
- Xiao ZhangXZXiao Zhang
- Zhenyu LinZLZhenyu Lin
- Yuan FengYFYuan Feng
- Haihong WangHWHaihong Wang
- Yongkang GaiYGYongkang Gai
- Hanyi FangHFHanyi Fang
- Kaixiong TaoKTKaixiong Tao
- Tao ZhangTZTao Zhang
- Xiaoli LanXLXiaoli Lan
Open Access
- 9 April 2026
- journal article
- Published by Elsevier in The EANM Journal
- Vol. 3
Abstract
No abstract availableFunding Information
- Shenzhen Municipal Fundamental Research Program (JCYJ20240813153408011)
- National Natural Science Foundation of China (82030052)
- National Natural Science Foundation of China (82372026)
- National Natural Science Foundation of China (82373050)
- National Natural Science Foundation of China (2025JBGS1003)
- National Natural Science Foundation of China (2024JBGS1004)
- Natural Science Foundation of Hubei Province (2025AFD771)
This publication has 37 references indexed in Scilit:
- Survival among patients treated with total mesorectal excision or selective watch-and-wait after total neoadjuvant therapy: a pooled analysis of the CAO/ARO/AIO-12 and OPRA randomized phase II trialsAnnals of Oncology, 2025
- Efficacy of pembrolizumab in microsatellite-stable, tumor mutational burden-high metastatic colorectal cancer: genomic signatures and clinical outcomesESMO Open, 2025
- Total neoadjuvant treatment using short-course radiotherapy and four CAPOX cycles in locally advanced rectal cancer with high-risk criteria for recurrence: a Swedish nationwide cohort study (LARCT-US)eClinicalMedicine, 2024
- Neoadjuvant short-course radiotherapy followed by camrelizumab and chemotherapy in locally advanced rectal cancer (UNION): early outcomes of a multicenter randomized phase III trialAnnals of Oncology, 2024
- Total Neoadjuvant Therapy With PD-1 Blockade for High-Risk Proficient Mismatch Repair Rectal CancerJAMA Surgery, 2024
- Long-term Quality of Life and Functional Outcome of Patients With Rectal Cancer Following a Watch-and-Wait ApproachJAMA Surgery, 2023
- Disposable amperometric immunosensor with a dual monomers-based bioconjugate for granzyme B detection in blood and cancer progress monitoring of patientsBiosensors and Bioelectronics, 2022
- The concept and use of the neoadjuvant rectal score as a composite endpoint in rectal cancerThe Lancet Oncology, 2021
- Fruquintinib: First Global ApprovalDrugs, 2018
- Atezolizumab versus docetaxel in patients with previously treated non-small-cell lung cancer (OAK): a phase 3, open-label, multicentre randomised controlled trialThe Lancet, 2017